Patents by Inventor Alvin Friedman-Kien

Alvin Friedman-Kien has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7968696
    Abstract: The present invention relates to viral interleukin-6 (v-IL-6), which can be obtained by recombinant expression of the DNA of human herpesvirus type 8 (HHV-8), and which may be used in diagnosis and treatment of human diseases such as kaposi sarcoma, Castleman's disease, multiple myeloma, kidney cell carcinoma, mesangial proliferative glomerulonephritis or B cell lymphoma.
    Type: Grant
    Filed: July 19, 1996
    Date of Patent: June 28, 2011
    Assignees: Behring Diagnostics GmbH, New York University
    Inventors: Bernhard Fleckenstein, Jens-Christian Albrecht, Frank Neipel, Alvin Friedman-Kien, Yao-Qi Huang
  • Patent number: 7109002
    Abstract: The present invention relates to viral interleukin-6 (v-IL-6), which can be obtained by recombinant expression of the DNA of human herpesvirus type 8 (HHV-8), and which may be used in diagnosis and treatment of human diseases such as kaposi sarcoma, Castleman's disease, multiple myeloma, kidney cell carcinoma, mesangial proliferative glomerulonephritis or B cell lymphoma.
    Type: Grant
    Filed: April 21, 2004
    Date of Patent: September 19, 2006
    Assignees: New York University School of Medicine, BehringDiagnostics GmbH
    Inventors: Bernhard Fleckenstein, Jens Christian Albrecht, Frank Neipel, Alvin Friedman-Kien, Yao Qi Huang
  • Publication number: 20040228838
    Abstract: The present invention relates to viral interleukin-6 (v-IL-6), which can be obtained by recombinant expression of the DNA of human herpesvirus type 8 (HHV-8), and which may be used in diagnosis and treatment of human diseases such as kaposi sarcoma, Castleman's disease, multiple myeloma, kidney cell carcinoma, mesangial proliferative glomerulonephritis or B cell lymphoma.
    Type: Application
    Filed: April 21, 2004
    Publication date: November 18, 2004
    Applicants: Behring Diagnostics GmbH, New York University
    Inventors: Bernhard Fleckenstein, Jens-Christian Albrecht, Frank Neipel, Alvin Friedman-Kien, Yao Qi Huang
  • Patent number: 5122446
    Abstract: Disclosed herein is a method of screening mammals for antibodies to viral agents by collecting a urine sample from a mammal to be tested and assaying the sample for antibodies directed against the specific viral agent.
    Type: Grant
    Filed: June 10, 1988
    Date of Patent: June 16, 1992
    Assignee: New York University
    Inventors: Alvin Friedman-Kien, Cao Yunzhen, William Borkowsky